Identification of genetic risk factors in the Chinese population implicates a role of immune system in Alzheimer’s disease pathogenesis
Alzheimer’s disease (AD) is a leading cause of mortality among the elderly. We performed a whole-genome sequencing study of AD in the Chinese population. In addition to the variants identified in or around the APOE locus (sentinel variant rs73052335, P = 1.44 × 10−14), two common variants, GCH1 (rs7...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 115; no. 8; pp. 1697 - 1706 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
20.02.2018
|
Series | Inaugural Article |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Alzheimer’s disease (AD) is a leading cause of mortality among the elderly. We performed a whole-genome sequencing study of AD in the Chinese population. In addition to the variants identified in or around the APOE locus (sentinel variant rs73052335, P = 1.44 × 10−14), two common variants, GCH1 (rs72713460, P = 4.36 × 10−5) and KCNJ15 (rs928771, P = 3.60 × 10−6), were identified and further verified for their possible risk effects for AD in three small non-Asian AD cohorts. Genotype–phenotype analysis showed that KCNJ15 variant rs928771 affects the onset age of AD, with earlier disease onset in minor allele carriers. In addition, altered expression level of the KCNJ15 transcript can be observed in the blood of AD subjects. Moreover, the risk variants of GCH1 and KCNJ15 are associated with changes in their transcript levels in specific tissues, as well as changes of plasma biomarkers levels in AD subjects. Importantly, network analysis of hippocampus and blood transcriptome datasets suggests that the risk variants in the APOE, GCH1, and KCNJ15 loci might exert their functions through their regulatory effects on immune-related pathways. Taking these data together, we identified common variants of GCH1 and KCNJ15 in the Chinese population that contribute to AD risk. These variants may exert their functional effects through the immune system. |
---|---|
Bibliography: | SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 This contribution is part of the special series of Inaugural Articles by members of the National Academy of Sciences elected in 2015. Contributed by Nancy Y. Ip, January 2, 2018 (sent for review September 6, 2017; reviewed by Michael P. Epstein, Alison Goate, and William Mobley) Reviewers: M.P.E., Emory University School of Medicine; A.G., Icahn School of Medicine at Mount Sinai; and W.M., University of California, San Diego. 3Part of the data used in the preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu/). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and provided data but did not participate in the analysis or writing of this report. A complete listing of ADNI investigators can be found in the SI Appendix. 1X.Z. and Yu Chen contributed equally to this work. Author contributions: X.Z., Yu Chen, K.Y.M., A.K.Y.F., and N.Y.I. designed research; X.Z., Yu Chen, K.Y.M., Q.Z., K.C., Yuewen Chen, and Q.G. performed research; A.D.N.I. contributed new reagents/analytic tools; X.Z., Yu Chen, K.Y.M., J.H., Y.L., A.K.Y.F., and N.Y.I. analyzed data; X.Z., Yu Chen, A.K.Y.F., and N.Y.I. wrote the paper; and A.D.N.I. partial data were obtained from the ADNI database. |
ISSN: | 0027-8424 1091-6490 1091-6490 |
DOI: | 10.1073/pnas.1715554115 |